Clinical Edge Journal Scan

Clinical Edge Journal Scan

Switching to extended-interval natalizumab dosing effective in RRMS

• Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Multiple Sclerosis May 2022

Author:

Mark Gudesblatt, MD

• Read More

Clinical Edge Journal Scan

A hormone therapy shows favorable treatment satisfaction in menopausal women with MS

• Read More

Clinical Edge Journal Scan

Pregnancy and the risk of developing multiple sclerosis: Is there a link?

• Read More

Clinical Edge Journal Scan

Patients with multiple sclerosis at an increased risk for cardiovascular diseases

• Read More

Clinical Edge Journal Scan

Maternal and infant outcomes in pregnant patients with MS treated with natalizumab

• Read More

Clinical Edge Journal Scan

Progression independent of relapse activity is a major cause of CDA in early relapsing MS

• Read More

Clinical Edge Journal Scan

Multiple sclerosis: B-cell depleting therapies hinder nAb response following SARS-CoV-2 vaccination

• Read More

Clinical Edge Journal Scan

Relapsing MS: Ofatumumab demonstrates superior benefit-risk profile than teriflunomide in RDTN patients

• Read More

Clinical Edge Journal Scan

Adverse childhood experiences associated with increased multiple sclerosis risk in women

• Read More